Generation and preclinical characterization of a novel bispecific CD19-TCRgammadelta antibody for the treatment of B cell acute lymphoblastic leukemia

IntroductionB-cell acute lymphoblastic leukemia (B-ALL) is characterized by the clonal expansion of immature lymphoblastic cells. Treating patients with disease relapse is challenging, especially after allogeneic stem cell transplantation (aSCT). Although the CD19xCD3 bispecific antibody (bsAb) blin...

Повний опис

Бібліографічні деталі

Автори:	Joseph Kauer, Fabian Vogt, Sebastian Hörner, Valentin Schmidt, Carsten Müller-Tidow, Simon Raffel, Helmut R. Salih, Gundram Jung, Martin Pflügler
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Frontiers Media S.A. 2026-02-01
Серія:	Frontiers in Immunology
Предмети:	acute lymphoblastic leukemia bispecific antibodies CD19 gammadelta T cells immunotherapy
Онлайн доступ:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1728424/full
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!